NNNN - Anbio Biotechnology Class A Ordinary Shares News

Sectors

NNNN

Anbio Biotechnology Class A Ordinary Shares

10.35

9 x 9.90

1 x 10.38

bid

ask

0.16

1.57%

1 @ 04:00 PM

10.35 +0.00 (0.00%)

Ytd	-65.58%
1y	-77.99%

9.66

day range

10.64

8.30

52 week range

54.95

Open	10.64	Prev Close	10.19	Low	9.66	High	10.64	Mkt Cap	454.27M
Vol	24.64K	Avg Vol	41.34K	EPS	0.07	P/E	149.57	Forward P/E	N/A
Beta	5.40	Short Ratio	1.79	Inst. Own	4.90%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	04-28	50-d Avg	14.37	200-d Avg	23.72	1yr Est	0.00

NNNN News

benzinga.com

Top 3 Health Care Stocks That May Rocket Higher In July

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock stre

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

defenseworld.net

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head-To-Head Contrast: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Financial Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Analyzing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Financial Comparison

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) Critical Analysis

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Reviewing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Analyzing Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Critical Survey: Anbio Biotechnology (NASDAQ:NNNN) versus Oncocyte (NASDAQ:IMDX)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Reviewing Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Head-To-Head Review

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Financial Contrast

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head to Head Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

benzinga.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

benzinga.com

Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%

Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks alread

benzinga.com

Dow Jumps Over 200 Points; ISM Services PMI Falls In September

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On T